UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ___________________ Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2011 Commission File Number 1-32186 ___________________ YM BioSciences Inc. (Translation of registrant's name into English) Suite 400, Building 11 5045 Orbitor Drive Mississauga, Ontario Canada L4W 4Y4 (Address of principal executive offices) ___________________ Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.) Form 20-F o Form 40-F þ Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1) £ Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7) £ |
INCORPORATION BY REFERENCE
This Form 6-K shall be incorporated by reference as an exhibit to the Registration Statement of YM BioSciences Inc. on Form S-8 (File No. 333-134410).
DOCUMENTS FILED
See the Exhibit Index hereto for a list of the documents filed herewith and forming a part of this Form 6-K.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| YM BIOSCIENCES INC. | ||
| By: /s/ Leonard Vernon | ||
| Name: Leonard Vernon | ||
| Title: Vice President, Finance and Administration |
Date: March 17, 2011
EXHIBIT INDEX
| Exhibit | Description |
| 99.1 | Amended and Restated Stock Option Plan |